Response Genetics (RGDX) Posts Q1 EPS Loss of $0.01, Tops Consensus by 8c
Tweet
Share
E-mailGet Alerts RGDX Hot Sheet
Join SI Premium – FREE
Response Genetics (NASDAQ: RGDX) reported Q1 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $5.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Nike (NKE) Tops Q1 EPS by 4c
- Cal-Maine Foods (CALM) Misses Q1 EPS by 79c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
